ABCC7 p.Arg347Asp

ClinVar: c.1039C>T , p.Arg347Cys ? , not provided
c.1040G>A , p.Arg347His D , Pathogenic
c.1040G>T , p.Arg347Leu D , Pathogenic
c.1040G>C , p.Arg347Pro D , Pathogenic
CF databases: c.1040G>C , p.Arg347Pro D , CF-causing ; CFTR1: This mutation destroys a Hha I restriciton site and creates an NcoI site and occurred in a family diagnosed as PS. The mutation have been identified and analyzed using the SSCP technique.
c.1040G>A , p.Arg347His D , CF-causing ; CFTR1: The patient is of Italian origin and carries the [delta]F508 mutation on the other chromosome. Initially we thought this was the same mutation as R347 because it destroys the same hhai site; however, R347H does not create the NcoI site.
c.1040G>T , p.Arg347Leu (CFTR1) D , A nucleotide change, G->T at position 1172, was detected leading to R347L. The other chromosome carries a [delta]F508. This mutation was found on one chromosome among 150 CF chromosomes screened.
c.1039C>T , p.Arg347Cys (CFTR1) ? , This mutation was identified by DGGE and direct sequencing.
Predicted by SNAP2: A: D (95%), C: D (95%), D: D (95%), E: D (95%), F: D (95%), G: D (95%), H: D (71%), I: D (95%), K: D (95%), L: D (80%), M: D (95%), N: D (95%), P: D (75%), Q: D (95%), S: D (95%), T: D (95%), V: D (95%), W: D (95%), Y: D (95%),
Predicted by PROVEAN: A: N, C: D, D: D, E: N, F: D, G: D, H: N, I: D, K: N, L: N, M: N, N: N, P: N, Q: N, S: N, T: N, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Zhang DW, Nunoya K, Vasa M, Gu HM, Theis A, Cole SP, Deeley RG
Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1.
Biochemistry. 2004 Jul 27;43(29):9413-25., 2004-07-27 [PMID:15260484]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Frelet A, Klein M
Insight in eukaryotic ABC transporter function by mutation analysis.
FEBS Lett. 2006 Feb 13;580(4):1064-84. Epub 2006 Jan 19., 2006-02-13 [PMID:16442101]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Cotten JF, Welsh MJ
Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge.
J Biol Chem. 1999 Feb 26;274(9):5429-35., 1999-02-26 [PMID:10026154]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Guinamard R, Akabas MH
Arg352 is a major determinant of charge selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel.
Biochemistry. 1999 Apr 27;38(17):5528-37., 1999-04-27 [PMID:10220340]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Walsh KB, Long KJ, Shen X
Structural and ionic determinants of 5-nitro-2-(3-phenylprophyl-amino)-benzoic acid block of the CFTR chloride channel.
Br J Pharmacol. 1999 May;127(2):369-76., [PMID:10385235]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Smith SS, Steinle ED, Meyerhoff ME, Dawson DC
Cystic fibrosis transmembrane conductance regulator. Physical basis for lyotropic anion selectivity patterns.
J Gen Physiol. 1999 Dec;114(6):799-818., [PMID:10578016]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Akabas MH
Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel.
J Biol Chem. 2000 Feb 11;275(6):3729-32., 2000-02-11 [PMID:10660517]

Abstract [show]
Comments [show]
Sentences [show]

[hide] McCarty NA
Permeation through the CFTR chloride channel.
J Exp Biol. 2000 Jul;203(Pt 13):1947-62., [PMID:10851114]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Clain J, Fritsch J, Lehmann-Che J, Bali M, Arous N, Goossens M, Edelman A, Fanen P
Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function.
J Biol Chem. 2001 Mar 23;276(12):9045-9. Epub 2000 Dec 15., 2001-03-23 [PMID:11118444]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Kogan I, Ramjeesingh M, Huan LJ, Wang Y, Bear CE
Perturbation of the pore of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibits its atpase activity.
J Biol Chem. 2001 Apr 13;276(15):11575-81. Epub 2000 Dec 21., 2001-04-13 [PMID:11124965]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Linsdell P
Relationship between anion binding and anion permeability revealed by mutagenesis within the cystic fibrosis transmembrane conductance regulator chloride channel pore.
J Physiol. 2001 Feb 15;531(Pt 1):51-66., 2001-02-15 [PMID:11179391]

Abstract [show]
Comments [show]
Sentences [show]

[hide] McCarty NA, Zhang ZR
Identification of a region of strong discrimination in the pore of CFTR.
Am J Physiol Lung Cell Mol Physiol. 2001 Oct;281(4):L852-67., [PMID:11557589]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Gupta J, Linsdell P
Point mutations in the pore region directly or indirectly affect glibenclamide block of the CFTR chloride channel.
Pflugers Arch. 2002 Mar;443(5-6):739-47. Epub 2001 Dec 8., [PMID:11889571]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Chen JH, Chang XB, Aleksandrov AA, Riordan JR
CFTR is a monomer: biochemical and functional evidence.
J Membr Biol. 2002 Jul 1;188(1):55-71., 2002-07-01 [PMID:12172647]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Kogan I, Ramjeesingh M, Li C, Kidd JF, Wang Y, Leslie EM, Cole SP, Bear CE
CFTR directly mediates nucleotide-regulated glutathione flux.
EMBO J. 2003 May 1;22(9):1981-9., 2003-05-01 [PMID:12727866]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Clain J, Lehmann-Che J, Dugueperoux I, Arous N, Girodon E, Legendre M, Goossens M, Edelman A, de Braekeleer M, Teulon J, Fanen P
Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype.
Hum Mutat. 2005 Apr;25(4):360-71., [PMID:15776432]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Caci E, Caputo A, Hinzpeter A, Arous N, Fanen P, Sonawane N, Verkman AS, Ravazzolo R, Zegarra-Moran O, Galietta LJ
Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis.
Biochem J. 2008 Jul 1;413(1):135-42., 2008-07-01 [PMID:18366345]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Cui G, Zhang ZR, O'Brien AR, Song B, McCarty NA
Mutations at arginine 352 alter the pore architecture of CFTR.
J Membr Biol. 2008 Mar;222(2):91-106. Epub 2008 Apr 18., [PMID:18421494]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Mornon JP, Lehn P, Callebaut I
Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces.
Cell Mol Life Sci. 2008 Aug;65(16):2594-612., [PMID:18597042]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Loo TW, Bartlett MC, Clarke DM
The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface.
Biochemistry. 2010 Aug 3;49(30):6352-7., 2010-08-03 [PMID:20590134]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Schwiebert EM
ABC transporter-facilitated ATP conductive transport.
Am J Physiol. 1999 Jan;276(1 Pt 1):C1-8., [PMID:9886914]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Sheppard DN, Welsh MJ
Structure and function of the CFTR chloride channel.
Physiol Rev. 1999 Jan;79(1 Suppl):S23-45., [PMID:9922375]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Dawson DC, Smith SS, Mansoura MK
CFTR: mechanism of anion conduction.
Physiol Rev. 1999 Jan;79(1 Suppl):S47-75., [PMID:9922376]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Schultz BD, Singh AK, Devor DC, Bridges RJ
Pharmacology of CFTR chloride channel activity.
Physiol Rev. 1999 Jan;79(1 Suppl):S109-44., [PMID:9922378]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Stahl M, Stahl K, Brubacher MB, Forrest JN Jr
Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101.
Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C67-76. doi: 10.1152/ajpcell.00225.2011. Epub 2011 Sep 21., [PMID:21940661]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Sheppard DN, Gray MA, Gong X, Sohma Y, Kogan I, Benos DJ, Scott-Ward TS, Chen JH, Li H, Cai Z, Gupta J, Li C, Ramjeesingh M, Berdiev BK, Ismailov II, Bear CE, Hwang TC, Linsdell P, Hug MJ
The patch-clamp and planar lipid bilayer techniques: powerful and versatile tools to investigate the CFTR Cl- channel.
J Cyst Fibros. 2004 Aug;3 Suppl 2:101-8., [PMID:15463939]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Linsdell P, Hanrahan JW
Adenosine triphosphate-dependent asymmetry of anion permeation in the cystic fibrosis transmembrane conductance regulator chloride channel.
J Gen Physiol. 1998 Apr;111(4):601-14., [PMID:9524141]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Seibert FS, Loo TW, Clarke DM, Riordan JR
Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.
J Bioenerg Biomembr. 1997 Oct;29(5):429-42., [PMID:9511928]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Linsdell P, Tabcharani JA, Hanrahan JW
Multi-Ion mechanism for ion permeation and block in the cystic fibrosis transmembrane conductance regulator chloride channel.
J Gen Physiol. 1997 Oct;110(4):365-77., [PMID:9379169]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Tabcharani JA, Linsdell P, Hanrahan JW
Halide permeation in wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels.
J Gen Physiol. 1997 Oct;110(4):341-54., [PMID:9379167]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Dawson DC, Smith SS
Cystic fibrosis transmembrane conductance regulator. Permeant ions find the pore.
J Gen Physiol. 1997 Oct;110(4):337-9., [PMID:9379166]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Zhao J, Zerhusen B, Xie J, Drumm ML, Davis PB, Ma J
Rectification of cystic fibrosis transmembrane conductance regulator chloride channel mediated by extracellular divalent cations.
Biophys J. 1996 Nov;71(5):2458-66., [PMID:8913585]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Linsdell P, Hanrahan JW
Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a mammalian cell line and its regulation by a critical pore residue.
J Physiol. 1996 Nov 1;496 ( Pt 3):687-93., [PMID:8930836]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Becq F, Verrier B, Chang XB, Riordan JR, Hanrahan JW
cAMP- and Ca2+-independent activation of cystic fibrosis transmembrane conductance regulator channels by phenylimidazothiazole drugs.
J Biol Chem. 1996 Jul 5;271(27):16171-9., [PMID:8663098]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Cheung M, Akabas MH
Identification of cystic fibrosis transmembrane conductance regulator channel-lining residues in and flanking the M6 membrane-spanning segment.
Biophys J. 1996 Jun;70(6):2688-95., [PMID:8744306]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Hipper A, Mall M, Greger R, Kunzelmann K
Mutations in the putative pore-forming domain of CFTR do not change anion selectivity of the cAMP activated Cl- conductance.
FEBS Lett. 1995 Nov 6;374(3):312-6., [PMID:7589561]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Gadsby DC, Nagel G, Hwang TC
The CFTR chloride channel of mammalian heart.
Annu Rev Physiol. 1995;57:387-416., [PMID:7539989]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Zhang ZR, McDonough SI, McCarty NA
Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator.
Biophys J. 2000 Jul;79(1):298-313., [PMID:10866956]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Cui G, Freeman CS, Knotts T, Prince CZ, Kuang C, McCarty NA
Two salt bridges differentially contribute to the maintenance of cystic fibrosis transmembrane conductance regulator (CFTR) channel function.
J Biol Chem. 2013 Jul 12;288(28):20758-67. doi: 10.1074/jbc.M113.476226. Epub 2013 May 24., [PMID:23709221]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Ziady AG, Hansen J
Redox balance in cystic fibrosis.
Int J Biochem Cell Biol. 2014 Jul;52:113-23. doi: 10.1016/j.biocel.2014.03.006. Epub 2014 Mar 20., [PMID:24657650]

Abstract [show]
Comments [show]
Sentences [show]